• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用免疫组织化学选择肿瘤抗原作为免疫攻击靶点:I. 聚焦神经节苷脂。

Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides.

作者信息

Zhang S, Cordon-Cardo C, Zhang H S, Reuter V E, Adluri S, Hamilton W B, Lloyd K O, Livingston P O

机构信息

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

出版信息

Int J Cancer. 1997 Sep 26;73(1):42-9. doi: 10.1002/(sici)1097-0215(19970926)73:1<42::aid-ijc8>3.0.co;2-1.

DOI:10.1002/(sici)1097-0215(19970926)73:1<42::aid-ijc8>3.0.co;2-1
PMID:9334808
Abstract

Understanding the distribution of tumor-associated antigens on cancers and normal tissues is essential for selection of targets for cancer immunotherapy. Seven carbohydrate antigens, potential targets for immunotherapy, were studied using a panel of well-characterized MAbs by immunohistochemistry on cryostat-cut tissue sections of 13 types of cancers and 18 normal tissues. GD2 and GD3 were present on most cancers of neuroectodermal origin and GD2 was also present on B cell lymphomas. 9-O-acetyl-GD3 was detected only on melanoma while fucosyl GM1 was detected only on small cell lung cancers (SCLC). Surprisingly, GM2 was strongly expressed on all tested tumors, including cancers of neuroectodermal origin and cancers of epithelial origin. Polysialic acid was primarily expressed on SCLC and neuroblastomas. Globo H was present on most cancers of epithelial origin. These antigens were also identified in normal tissues. Fucosyl GM1 was not expressed significantly on any of the normal tissues analyzed. GD3, GD2, GM2 and polysialic acid were detected in normal brain to varying degrees. GM2 and Globo H were expressed on the luminal surface of epithelia of a variety of organs. The unexpected expression of GM2 on a broad range of cancers and normal epithelial tissues was confirmed by loss after methanol fixation and by immune thin layer chromatography.

摘要

了解肿瘤相关抗原在癌症组织和正常组织中的分布情况对于癌症免疫治疗靶点的选择至关重要。使用一组经过充分表征的单克隆抗体,通过免疫组织化学方法,在13种癌症和18种正常组织的低温切片上研究了7种碳水化合物抗原(免疫治疗的潜在靶点)。GD2和GD3存在于大多数神经外胚层起源的癌症中,GD2也存在于B细胞淋巴瘤中。9-O-乙酰-GD3仅在黑色素瘤中检测到,而岩藻糖基GM1仅在小细胞肺癌(SCLC)中检测到。令人惊讶的是,GM2在所有测试的肿瘤中均强烈表达,包括神经外胚层起源的癌症和上皮起源的癌症。聚唾液酸主要表达于小细胞肺癌和神经母细胞瘤中。Globo H存在于大多数上皮起源的癌症中。这些抗原在正常组织中也有发现。在所分析的任何正常组织中,岩藻糖基GM1均未显著表达。GD3、GD2、GM2和聚唾液酸在正常脑组织中均有不同程度的检测到。GM2和Globo H在多种器官上皮的腔表面表达。甲醇固定后GM2的消失以及免疫薄层色谱法证实了GM2在广泛的癌症和正常上皮组织中的意外表达。

相似文献

1
Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides.利用免疫组织化学选择肿瘤抗原作为免疫攻击靶点:I. 聚焦神经节苷脂。
Int J Cancer. 1997 Sep 26;73(1):42-9. doi: 10.1002/(sici)1097-0215(19970926)73:1<42::aid-ijc8>3.0.co;2-1.
2
Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy.选择GM2、岩藻糖基GM1、球节H和多唾液酸作为小细胞肺癌抗体介导免疫治疗的靶点。
Cancer Immunol Immunother. 2005 Oct;54(10):1018-25. doi: 10.1007/s00262-005-0663-8. Epub 2005 May 31.
3
A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell surface reactivity.一种检测N-乙酰基和N-糖基化神经节苷脂GM2的鼠单克隆抗体:细胞表面反应性的表征
Cancer Res. 1986 Aug;46(8):4116-20.
4
Recombinant antibodies against ganglioside expressed on tumor cells.针对肿瘤细胞上表达的神经节苷脂的重组抗体。
Cancer Chemother Pharmacol. 2000;46 Suppl:S13-7. doi: 10.1007/pl00014042.
5
Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse.小鼠用神经节苷脂GM1、GM2、GM3、GD2和GD3免疫后的抗体反应。
Cancer Immunol Immunother. 1989;29(3):179-84. doi: 10.1007/BF00199993.
6
Generation of two murine monoclonal antibodies that can discriminate N-glycolyl and N-acetyl neuraminic acid residues of GM2 gangliosides.两种能够区分GM2神经节苷脂的N-羟乙酰神经氨酸和N-乙酰神经氨酸残基的小鼠单克隆抗体的产生。
Cancer Res. 1988 Nov 1;48(21):6154-60.
7
Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis.双唾液酸神经节苷脂GD2的生物合成与表达,GD2是小细胞肺癌上一种用于单克隆抗体介导细胞溶解的相关靶抗原。
Cancer Res. 1986 Oct;46(10):5112-8.
8
Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.通过定量免疫薄层色谱法评估人类恶性黑色素瘤上的神经节苷脂表达。
Int J Cancer. 1993 Feb 20;53(4):566-73. doi: 10.1002/ijc.2910530407.
9
Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues.单克隆抗体与人小细胞肺癌组织中神经节苷脂抗原的反应性。
Lung Cancer. 2000 Apr;28(1):29-36. doi: 10.1016/s0169-5002(99)00107-5.
10
Ganglioside antigens in tissue sections of skin, naevi, and melanoma--implications for treatment of melanoma.皮肤、痣和黑色素瘤组织切片中的神经节苷脂抗原——对黑色素瘤治疗的启示
Cancer Treat Res. 1991;54:137-51. doi: 10.1007/978-1-4615-3938-4_8.

引用本文的文献

1
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous system.GD2:治疗中枢神经系统肿瘤儿科患者的希望与挑战
NPJ Precis Oncol. 2025 Aug 21;9(1):295. doi: 10.1038/s41698-025-01079-1.
2
The Immune Microenvironment in Prostate Cancer: A Comprehensive Review.前列腺癌中的免疫微环境:综述
Oncology. 2024 Oct 9:1-25. doi: 10.1159/000541881.
3
Phase I-II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors.
OBI-888 是一种针对肿瘤相关碳水化合物抗原 Globo H 的人源化单克隆 IgG1 抗体,在晚期实体瘤患者中的 I- II 期研究。
Cancer Chemother Pharmacol. 2024 Dec;94(6):787-798. doi: 10.1007/s00280-024-04714-z. Epub 2024 Sep 23.
4
Development of NHAcGD2/NHAcGD3 conjugates of bacteriophage MX1 virus-like particles as anticancer vaccines.噬菌体MX1病毒样颗粒的NHAcGD2/NHAcGD3缀合物作为抗癌疫苗的研发。
RSC Adv. 2024 Feb 19;14(9):6246-6252. doi: 10.1039/d3ra08923a. eCollection 2024 Feb 14.
5
A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [Cu]Cu-NOTA-ch14.18/CHO.通过 PET 和 [Cu]Cu-NOTA-ch14.18/CHO 对小儿肿瘤进行 GD2 靶向治疗的新方法。
Theranostics. 2024 Jan 20;14(3):1212-1223. doi: 10.7150/thno.92481. eCollection 2024.
6
Increased expression of SSEA-4 on TKI-resistant non-small cell lung cancer with EGFR-T790M mutation.TKI 耐药的伴有 EGFR-T790M 突变的非小细胞肺癌中 SSEA-4 的表达增加。
Proc Natl Acad Sci U S A. 2024 Jan 30;121(5):e2313397121. doi: 10.1073/pnas.2313397121. Epub 2024 Jan 22.
7
The cancer glycocode as a family of diagnostic biomarkers, exemplified by tumor-associated gangliosides.作为诊断生物标志物家族的癌症糖代码,以肿瘤相关神经节苷脂为例。
Front Oncol. 2023 Oct 26;13:1261090. doi: 10.3389/fonc.2023.1261090. eCollection 2023.
8
Small Cell Lung Cancer: Emerging Targets and Strategies for Precision Therapy.小细胞肺癌:精准治疗的新兴靶点与策略
Cancers (Basel). 2023 Aug 8;15(16):4016. doi: 10.3390/cancers15164016.
9
9-O Acetylated Gangliosides in Health and Disease.9-O 乙酰化神经节苷脂在健康和疾病中的作用。
Biomolecules. 2023 May 12;13(5):827. doi: 10.3390/biom13050827.
10
Mechanism of Antigen Presentation and Specificity of Antibody Cross-Reactivity Elicited by an Oligosaccharide-Conjugate Cancer Vaccine.寡糖结合癌症疫苗诱导的抗原呈递机制和抗体交叉反应特异性。
J Am Chem Soc. 2023 May 3;145(17):9840-9849. doi: 10.1021/jacs.3c02003. Epub 2023 Apr 23.